Podcasts about fda approved

Extra Extra, Read all about it! Actually, it's a podcast, Listen all about it!  New Pain Med! New Pain Med! New Non-Opioid Pain Med! Suzetrigine (Journavx) is now FDA Approved for Moderate to Severe Acute Pain in Adults, but what fun facts come along with it????? We turn to the Simpsons, Brugada, and enjoy some club seats while succinctly reviewing everything there is to know about this new non-opioid pain medication on the Pain Pod! Come one, come all, to the Pain Pod!!! Pain Guy • www.painguy.us  

Extra Extra, Read all about it! Actually, it's a podcast, Listen all about it!  New Pain Med! New Pain Med! New Non-Opioid Pain Med! Suzetrigine (Journavx) is now FDA Approved for Moderate to Severe Acute Pain in Adults, but what fun facts come along with it????? We turn to the Simpsons, Brugada, and enjoy some club seats while succinctly reviewing everything there is to know about this new non-opioid pain medication on the Pain Pod! Come one, come all, to the Pain Pod!!! Pain Guy • www.painguy.us  

Helo & Airline Crash Pt.2, New Pain Drug FDA Approved, Confirmation Highlights & Fake StoriesJoin Matt, Amy and Olivia tonight at 7pm A-BLOCK: Helo and Airline Crash Pt.2B-BLOCK: New Pain Drug FDA ApprovedC-Block: Best Moments From ConfirmationD-Block: Fake StoriesF-Block: Overtime Random StoriesWatch the Live Show on the following channels: linktapgo.com/thedumshowBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-dum-show--6012883/support.

Welcome to Santa Clarita Real Estate Insights & Beyond, a 4-part podcast series hosted by Connor, where we explore the dynamic world of real estate, personal growth, and the future of technology. Each episode is packed with actionable advice, market updates, and thought-provoking discussions to help you navigate the complexities of modern life. Whether you're a buyer, seller, or simply curious about the world around you, this podcast offers something for everyone.Episode 1: Santa Clarita Real Estate Market UpdateIn the first episode, Connor dives into the latest Santa Clarita real estate market trends. With a detailed breakdown of active listings, price adjustments, and market activity, you'll gain a clear understanding of where the market stands as of January 26th. Connor also shares valuable tips for buyers and sellers, discusses the impact of interest rates, and explores how local developments—like new housing projects and freeway expansions—are shaping the future of Santa Clarita. Whether you're looking to buy, sell, or invest, this episode equips you with the knowledge to make informed decisions.Episode 2: Weight Loss, Fasting, and the GLP-1 Agonist RevolutionIn this episode, Connor shifts gears to tackle a topic close to his heart: weight loss and health. Drawing from his personal journey of losing 135 pounds, he shares insights into fasting, hormone therapy, and the role of discipline in achieving long-term health goals. Connor also delves into the controversial world of GLP-1 agonists like Ozempic and Wegovy, discussing their benefits, risks, and the importance of maintaining muscle mass while using these medications. Whether you're struggling with weight loss or simply curious about the latest health trends, this episode offers practical advice and a fresh perspective.Episode 3: The Rise of Post-Human Intelligence (PSI)Artificial intelligence is no longer science fiction—it's here, and it's evolving faster than ever. In this thought-provoking episode, Connor explores the concept of Post-Human Intelligence (PSI), discussing how AI is surpassing human capabilities in creativity, problem-solving, and even empathy. From large language models like ChatGPT and Gemini to the ethical implications of self-learning systems, Connor breaks down the complexities of AI in an accessible way. He also shares his concerns about the future of AI and how we can prepare for a world where machines may outthink us. This episode is a must-listen for anyone curious about the future of technology and its impact on humanity.Episode 4Youtube Channels:Conner with Honor - real estateHome Muscle - fat torchingFrom first responder to real estate expert, Connor with Honor brings honesty and integrity to your Santa Clarita home buying or selling journey. Subscribe to my YouTube channel for valuable tips, local market trends, and a glimpse into the Santa Clarita lifestyle.Dive into Real Estate with Connor with Honor:Santa Clarita's Trusted Realtor & Fitness EnthusiastReal Estate:Buying or selling in Santa Clarita? Connor with Honor, your local expert with over 2 decades of experience, guides you seamlessly through the process. Subscribe to his YouTube channel for insider market updates, expert advice, and a peek into the vibrant Santa Clarita lifestyle.Fitness:Ready to unlock your fitness potential? Join Connor's YouTube journey for inspiring workouts, healthy recipes, and motivational tips. Remember, a strong body fuels a strong mind and a successful life!Podcast:Dig deeper with Connor's podcast! Hear insightful interviews with industry experts, inspiring success stories, and targeted real estate advice specific to Santa Clarita.

For bird enthusiasts, hearing about the negative impacts of habitat loss on bobwhite quail isn't anything new. In fact, this issue have been largely blamed for North America's shrinking bobwhite population. However, parasites may have a larger effect on wild quail than previously thought, especially in Texas and Oklahoma. “Something happened,” said Dr. Ron Kendall, the founder of Texas Tech's Wildlife Toxicology Lab. “We saw innumerable quail in the summer of 2010. Conditions were perfect. But by that fall, the quail were gone.” That year, biologists, wildlife managers, researchers, and hunters rallied together and launched "Operation Idiopathic Decline." The operation brought together multiple universities. Scientists explored the potential causes of the quail population crash. “We looked at pesticides, environmental contaminants, viruses, bacteria, and parasites,” said Dr. Kendall. “Lo and behold, we saw these parasitic worms called helminths in the birds.” 

Stock market update for January 21, 2025. Check out our Instagram account @TheRundownDaily

Mesoblast Limited CEO Silviu Itescu joined Steve Darling from Proactive to share news the company has announced the U.S. Food and Drug Administration has approved remestemcel-L, now marketed under the brand name Ryoncil, as the first and only therapy for steroid-refractory acute graft-versus-host disease (SR-aGVHD) in children aged two months and older, including adolescents. This milestone FDA approval is based on results from a phase III clinical trial that demonstrated the efficacy of Ryoncil in treating SR-aGVHD. Among children with high-severity Grade C or Grade D disease, 70% achieved an overall response by Day 28, a critical measure strongly associated with improved survival outcomes in aGVHD. The approval marks a significant breakthrough for this devastating condition, which has an extremely poor prognosis and limited treatment options. Each year, approximately 10,000 patients in the U.S., including 1,500 children, undergo allogeneic bone marrow transplants, with nearly half developing aGVHD. Of those cases, around 50% become steroid-resistant, leaving patients with few effective therapeutic options. The company is actively preparing for the U.S. market launch of Ryoncil, focusing on ensuring that children and adolescents battling this life-threatening disease have access to the first approved therapy of its kind. Mesoblast has two more products in its pipeline nearing FDA approval: a cardiovascular treatment, REVASCOR, which showed significant reductions in heart attacks and mortality, and a back pain therapy that provides long-lasting relief from a single injection. Both products represent multi-billion dollar opportunities. #proactiveinvestors #mesoblastlimited #asx #msb #nasdaq #meso FDAApproval #Ryoncil #MSCtherapy #BiotechInnovation #GvHD #MedicalBreakthrough #InflammatoryConditions #ProactiveInvestors #CellTherapy

BUFFALO, NY - December 30, 2024 – A new #editorial was #published in Oncotarget's Volume 15 on December 24, 2024, titled “Pitfalls and perils from FDA-approved germ-line cancer predisposition tests." Authored by Dr. Wafik S. El-Deiry, Editor-in-Chief of Oncotarget, and Dr. Eli Y. Adashi from Brown University, the article highlights concerns about the risks of a newly approved genetic test for cancer risk. This test, called the “Invitae Common Hereditary Cancers Panel," was approved in 2023 and examines 48 genes linked to inherited cancers, including breast, ovarian, and Lynch syndrome-related cancers. Although the test increases access to genetic information, the authors warn that using it without professional guidance may lead to confusion, stress, and potential harm. One concern is that people can order this test online without consulting healthcare professionals or genetic counselors. Without expert help, users might struggle to understand their results especially if they indicate risks that are unclear or difficult to act on. This can cause unnecessary anxiety and confusion. “The DTC option of germ-line testing for cancer susceptibility should be discouraged given the risks of anxiety, lack of adequate interpretation for variants not strongly associated with cancer, potential for minors to be tested outside the healthcare system and potential for loss of follow-up if test results are not shared with health care professionals or never make it into the medical record.” The editorial also points out ethical and medical issues when minors use these tests. If a child's test is done without medical oversight, results might not be added to their health records, making follow-up care harder to manage and potentially risking their long-term health. Cost is another issue. These tests are often not covered by insurance, which can place a financial burden on families who might need additional testing or medical advice. The researchers emphasize that genetic testing for cancer risk should always include healthcare providers and genetic counseling. This ensures users fully understand their results and receive proper guidance. The authors also call on the US Food and Drug Administration (FDA) to provide clear rules for using these tests, particularly for minors. In conclusion, while genetic testing holds great potential for improving cancer prevention and care, its benefits must not come at the cost of safety and public health. Responsible use of these tests will require collaboration between regulators, healthcare professionals, and testing companies to address the risks and ensure these tools are used effectively. DOI - https://doi.org/10.18632/oncotarget.28677 Correspondence to - Wafik S. El-Deiry - wafik@brown.edu Video short - https://www.youtube.com/watch?v=DjKpiBNDWHo Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science). To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

Dominique Jean Larrey lived quite a life. He was born in 1766, and at the age of 13, had to walk from his home in a French village to study in the city of Toulouse. That journey was 70 miles, and yes, he walked it. That would be important much later in his life, when he found himself walking through the bitter cold in Russia as the Chief Surgeon of Napoleon's army. During that time, Napoleon's troops had to contend with the reality of Russian cold and temperatures that got as low as -37 degrees Celsius, which is about -35 Fahrenheit.Larrey attributed his ability to withstand the cold to his walking. But many of the soldiers around him wound up with frostbite, and to treat them, Larrey suggested slowly rewarming the affected area and rubbing it with snow. Frostbite treatment has been on quite the journey since then, and it was just earlier this year that the FDA approved the first drug to treat frostbite in the US, which is exciting news for the doctors who see cases of frostbite and for patients who are often left with the horrific reality of amputation. Send us your science stories/factoids/news for a chance to be featured on an upcoming Tiny Show and Tell Us bonus episode and to be entered to win a Tiny Matters coffee mug! And, while you're at it, subscribe to our newsletter at bit.ly/tinymattersnewsletter.Links to the Tiny Show & Tell story are here and here. All Tiny Matters transcripts and references are available here.

Hey how are you doing today? Do you feel good? Are you feeling good about yourself? If not, have I got the product for you - a lil substance you can inject to spawn a hotter version of yourself who will ruin your life. Are you interested?  We're talking THE SUBSTANCE (2024), a very weird and disgusting and delightful film we can not recommend highly enough. Don't cheat yourself out of watching this without spoilers! And ladies, remember - you're more than just one b00b Follow us on Bluesky: https://bsky.app/profile/noshowmonster.bsky.social Follow us on Instagram: https://www.instagram.com/noshowmonster/ Email us at noshowmonster@gmail.com Follow Kelly Attaway Bluesky: https://bsky.app/profile/kellyattaway.bsky.social Instagram: https://www.instagram.com/spooky_kellyyy/ Follow Chelsea Hollander lol SIKE you can't she's not online because she values her mental health and wellbeing  Hosted by Kelly Attaway and Chelsea Hollander Produced by Kelly Attaway Art by Ryan Tate Theme by Unicorn Heads    

Don't let sleep apnea disrupt your nights—or your health—any longer. Texas Sinus & Snoring (346-413-9313) offers a wide range of sleep disorder treatments, including Inspire therapy. Schedule a no-obligation consultation at https://texassinusandsnoring.com/services/sleep-apnea/inspire-sleep-therapy/ to see if Inspire therapy is right for you. Texas Sinus and Snoring City: Spring Address: 2940 Farm to Market 2920 Website: https://texassinusandsnoring.com/ Phone: +1 346 413 9313 Email: Info@texassinusandsnoring.com

The U.S. Food and Drug Administration has approved cannabis-derived medications for several indications. In this episode, family practitioner Randy Easterling, MD, highlights the current regulatory status of FDA-approved cannabis-derived medications and their approved uses.     ⭐⭐⭐⭐⭐

Kate Willis is an esteemed leader in Healthcare and MedTech, known for her strategic prowess and innovative approaches. Currently, she serves as the Vice President of Commercialization at Neurovalens, responsible for leading all global and US commercial functions, including the US launch. Her career highlights include serving as the Director of Government Affairs and Advocacy, where she has been a powerful force in shaping industry standards and policies.Kate's robust track record of leadership extends through premier companies such as Nevro, Medtronic, Nuvasive, and Zimmer Biomet, where her initiatives have not only spurred organizational growth but have also earned her multiple accolades. These honors include prestigious recognitions such as multiple President's Club awards, Sales Rep of the Year, and Rookie of the Year. Beyond her healthcare expertise, Kate is a recognized figure in the arts as a producer and investor, with successful ventures in Broadway, West End, and film productions. Her unique flair for bridging the realms of business and entertainment underlines her diverse capabilities and visionary outlook. SHOWNOTES:

The diagnostic paradigm for Alzheimer's disease (AD) has rapidly shifted in the last five years as fluid-based biomarker testing has emerged as a reliable, accurate, and accessible means to detect amyloid pathology when evaluating a patient for cognitive decline. This podcast is designed to help pathologists and laboratory professionals gain an understanding of plasma testing for markers such as Abeta40/42, P-tau181, and P-tau217 which are rapidly appearing in the commercial space and how healthcare providers have begun incorporating these tests into routine neurology practice. This podcast will help participants to understand the advantages and limitations of these assays as well as their potential application when a physician is evaluating a patient for AD. 

Rexulti. Power of Attorney for NIL. Podcasting, for who?

CME credits: 1.25 Valid until: 15-10-2025 Claim your CME credit at https://reachmd.com/programs/cme/navigating-therapy-exploring-fda-approved-treatments-for-effective-aad-care/27101/ This series of bite-sized episodes contains important information on diagnosing and treating agitation in Alzheimer's disease (AAD). Drs. Anton Porsteinsson and Brendan Montano discuss best practices for recognizing early symptoms, diagnosing patients, and treating their AAD.

CME credits: 1.00 Valid until: 15-10-2025 Claim your CME credit at https://reachmd.com/programs/cme/limitations-of-current-treatments-fda-approved-and-off-label-approaches/28625/ Patients with PTSD suffer from a range of psychiatric symptoms that severely reduce their quality of life. PTSD has proven to not only be a complicated diagnosis, but also one that has a low index of suspicion. Many patients are not screened for PTSD, and those who are diagnosed often gain little benefit from currently available treatments. Join us as these issues are dissected by Drs. Joseph Goldberg and Roger McIntyre, with the objective of providing clinicians with key action steps to take to improve outcomes for patients affected by PTSD.

Guests: Ross O'Neill Ph.D (Founding CEO) & Hubert Lim Ph.D (Chief Scientific Officer) of Neuromod Dave is joined by Ross & Hubert to discuss: - The backstory of how Ross & Hubert met and ultimately partnered together on Lenire - Hubert's research and papers he wrote about paired stimulation & Pavlovian conditioning, which included data that identified tongue stimulation combined with sound as a promising direction to pursue - An overview of what exactly tinnitus is and why Lenire presents such a novel approach to treating tinnitus - Other types of synchronous-stimuli approaches that have emerged in other healthcare verticals (i.e. mirror therapy for phantom limb pain) - The challenging process of gaining FDA approval and the clinical trials that were conducted throughout the process - Being featured as the cover story on Nature Communications - The initial roll-out of Lenire, the current state of the provider network, and the real-world data that's being collected and published

I dive deep into the illusion of safety behind FDA approvals and doctor recommendations. I unpack the shocking reality that the FDA, the very agency tasked with protecting public health, is often funded by the same conglomerates it's supposed to regulate. From fast-tracked pharmaceuticals to harmful food additives like aspartame and glyphosate, I reveal how corporate interests and profit often overshadow genuine concern for our well-being. Exploring conflicts of interest embedded within the system, like the opioid crisis, I challenge the notion that “doctor-recommended” always means safe. I urge you to become your own health advocate, question the system, and reconnect with nature to truly reclaim your health. This episode is a must-listen for anyone ready to break free from blind trust in labels and take control of their wellness journey. Resources:  Puori Supplements discount code: HEALINGTHESOURCE for 20% off your order sitewide (don't miss out PW1 grass-fed protein powder and CP1 collagen!!) Follow the host, Claudia Gilani, here, and check out HealingTheSource.org

Tune in to Episode 18 of the Full-Arch Secrets Podcast, where we speak with Dr. Michael Klein of Keystone Dental Group about the revolutionary Nexus IOS digital art system.In this episode, you'll explore:The challenges of traditional full-arch restoration methods and the need for precisionHow Nexus IOS, an FDA and ISO-certified digital process, reduces treatment time and ensures accurate resultsThe benefits of this technology in improving patient experience with enhanced comfort and aestheticsKeystone's unmatched warranty and commitment to qualityProven success with over 35,000 implants restored using Nexus IOSEpisode 18 is packed with insights to transform your approach and set your practice apart. Don't miss it!Ready to 10X Your Implant Practice?Schedule a FREE Consultation and find out how DIM can help you skyrocket your growth!Get Social With DIM: LinkedInFacebookInstagram

"Explore the revolutionary FDA-approved liver-directed therapy for metastatic uveal melanoma in our latest discussion with Dr. Chmielowski from UCLA. Discover how this groundbreaking treatment is making strides in patient care and what it means for future oncological practices. Learn about the therapy's development, its impact on patient outcomes, and UCLA's role in advancing treatment options. Tune in to uncover how this innovative approach is reshaping the treatment landscape for uveal melanoma."

Let's meet Cathy Goldstein, MD as she talks to SleepTech Talk about some exciting new technology in portable sleep studies. Dr Goldstein was the principle investigator (PI) for validation study Huxley Medical's latest FDA approved portable PSG unit, Sansa. She talks to us about why it's different and how it will help even more patients. Dr Cathy Goldstein is a Professor of Neurology at University of Michigan. She is also an internationally recognized expert in sleep tracking and sleep tracking technology. Dr Goldstein serves as a senior editor of Principles and Practices of Sleep Medicine and holds editorial roles for the Journal of Clinical Sleep Medicine. Listen in as we talk to Dr Goldstein and dive into her wealth of knowledge. A huge thanks to our sponsors: Medbridge Healthcare: For Job Opportunities with MedBridge Healthcare click here: https://medbridgehealthcare.com/careers/ Don't forget to Like, Share, Comment, and Subscribe! Learn more about the show at https://www.sleeptechtalk.com/thetechroom Credits: Audio/ Video: Diego R Mann; Music: Pierce G Mann Hosts: J. Emerson Kerr, Robert Miller, Gerald George Mannikarote Copyright: ⓒ 2024 SleepTech Talk Productions Sleep apnea, OSA, obstructive sleep apnea, dental appliance, oral appliance, oral sleep appliance, inspire, surgery, sleep surgery, CPAP

As of 2019, there are urine-free FDA-approved bioidentical hormones that skirt the standardization concerns of compounded preparations. Are they any safer?

Links and updates for Summer 2024Original post: https://www.experimental-history.com/p/bloodletting-leeches-and-other-fdaAll posts: https://www.experimental-history.com/Music by Brandon Rosiar, photos by my dad

An FDA-approved wonder weight-loss drug that's faster and less side-effect-prone than Semaglutide?! Dr. Kristen is here to spill the hottest tea on Tirzepatide, revealing why this game-changing drug is stealing the spotlight. But wait, it gets even crazier—discover how Tirzepatide is delivering mind-blowing benefits like boosting PCOS fertility and possibly even tackling dementia. Tune in because this revolutionary drug could be the ultimate game-changer for your health and wellness journey! TIMESTAMPS:00:00 Tirzapetide: A miracle weight loss drug?02:45 The shocking differences between Tirzepatide and Semaglutide.03:52 How to avoid the dark side of weight loss drugs.06:44 Dr. Kristen's proven protocol for lasting weight loss success.07:02 Breakthrough benefits of GLP 1 Agonists: What the media isn't telling you.11:55 The future of weight loss: What's next for GLP 1 Agonists? LINKS:FIND US AThttps://www.theperfectdose.net/FOLLOW US ON SOCIAL MEDIA: https://www.instagram.com/the_perfectdose/SUBSCRIBE TO OUR YOUTUBE CHANNEL:https://www.youtube.com/@theperfectdoseThe Perfect Dose Podcast is produced by Live Your Truth Media: https://www.liveyourtruth.media/

The smart ring has long played second fiddle to the smart watch. While tech giants like Apple and Google duked it out over wrists for years, the ring has been significantly quieter, a space where plucky startups have a chance to make their mark. Things are quickly changing, however. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Recently, the FDA approved a genetic test for opioid use disorder despite clear opposition from scientists and the FDA advisory panel that had reviewed the evidence. The case demonstrates the space where Pharma's incentive may drive innovation that may not help–or worse, cause harm. Abdul reflects on how genetic essentialism and the wrong incentives can reinforce each other. Than he speaks with Dr. Elizabeth Joniak-Grant, a sociologist and patient advocate who voted against the genetic test. This show would not be possible without the generous support of our sponsors. America Dissected invites you to check them out. This episode was brought to you by: Marguerite Casey Foundation invites you to sign up for their new Summer School program at caseygrants.org/summerschool. Henson Shaving invites you to find the razor that will last you a lifetime. Go to https://hensonshaving.com and enter AD at checkout to get 100 free blades with your purchase. (Note: you must add both the 100-blade pack and the razor for the discount to apply.) Blueland invites you to celebrate Plastic Free July with up to 25% off your Blueland order. Go to Blueland.com/america now for your special limited time offer.

Worried you might have sleep apnea but not ready to spend the night in a lab? The WatchPAT One sleep apnea test kit is FDA approved for use at home. Visit https://athomesleepapneatesting.com for details. At Home Sleep Apnea Testing City: Thousand Oaks Address: 317 S. Moorpark Rd, Thousand Oaks, CA 91361 Website: https://athomesleepapneatesting.com/ Phone: +1 805 557 9930 Email: support@athomesleepapneatesting.com

Alzheimer's Association Vice President of Programs Sarah Lovegreen and Megan Lynch discuss new Alzheimer's treatments that were recently approved.

In this episode, Dr. Ellen Marmur explains how different colors of LED light emitted from the MMsphereTM modulate cellular activity, skin physiology, and mood in unique ways. Her patented skincare technology augments the benefits of LED light and includes adaptogens, pre-probiotics and photodynamic actives that respond to LED light. DISCLAIMER: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.

For the first time ever, the FDA has approved an over the counter birth control pill. Jordan D'Nelle discusses the specifics of this groundbreaking progesterone-only birth control method, discussing its benefits, usage, and implications for accessible reproductive health. You can find Jordan D'Nelle on Instagram @jordandnelle. Enhance your self-awareness by acknowledging and understanding your behavior patterns, and foster a deeper connection with your inner self. Get the Unleashing My Power: A Women's Empowerment and Gratitude Journal to reclaim your personal power through the practice of daily gratitude and reflection. Learn more HERE. Follow Jordan D'Nelle on Facebook and Instagram @jordandnelle. Email: JordanDnelle@VaginasVulvasandVibrators.com Support the Vaginas, Vulvas, and Vibrators podcast! Join the Patreon community: patreon.JordanDnelle.com Leave an honest review on iTunes. Your ratings and reviews help this podcast impact more lives! Subscribe to Vaginas, Vulvas, and Vibrators on iTunes if you haven't already! *Disclaimer: This podcast is for informational and/or entertainment purposes only and is not a substitute for medical advice, diagnosis, or treatment. jordandnelle.com --- Support this podcast: https://podcasters.spotify.com/pod/show/jordan-dnelle/support

Dr. Ben Thompson reviews Lenire, an FDA-approved device to treat tinnitus. Get started with Treble Health:Schedule a complimentary telehealth consultation: treble.health/free-telehealth-consultation Take the tinnitus quiz: https://treble.health/tinnitus-quiz-1Download the Ultimate Tinnitus Guide: 2024 Edition: https://treble.health/tinnitus-guide-2024

On this week's Tech Nation, Moira speaks with Dr. Sam Blackman, Founder and Head of Research and Development from Day One Biopharmaceuticals talks about their innovative approach to starting a biopharma company and how it led to a newly FDA approved drug that treats the most common form of brain cancer in children. Then, Dr. Daniel Kraft, Tech Nation Health, Chief Correspondent, talks about the rise of Robotic and Digitally-Enabled surgeries. And, Futurist and regular Tech Nation contributor, Dr. Alex Pang,  gives us a quick word on how to better manage the stress of life these days.

In this episode, we talk to Irene Laurora, SVP of Scientific Affairs, and Flavia Mason, global VP of women's health at Perrigo, a consumer health company. Their over the counter birth control, Opill, was the first to receive FDA approval in the US, a significant step towards decreasing barriers for women to access quality healthcare. Join us for a conversation where we discuss the societal role of hormonal birth control, Perrigo's journey to securing FDA approval for Opill, and whether Opill is right for you.Remember to like, rate, and subscribe. Enjoy the episode!Guest bioIrene Laurora is a pharmacist by training who has spent her career in the pharmaceutical industry working to build solutions that make people's lives better and healthier. She currently serves as the SVP of Scientific Affairs at Perrigo, where she has played an instrumental role in the development of products like Opill.Flavia Mason is the Global VP of Women's Health at Perrigo. She came to this role after many years in corporate America, where she proved herself to be a strong leader and capable operator. She joined Perrigo to help improve women's experiences when interacting with the healthcare system.Organization bioPerrigo is a consumer health company responsible for securing FDA approval for the first over the counter birth control in the US, the Opill. Perrigo is behind many of the personal health brands you may be familiar with and see at your local pharmacy. With the addition of the Opill, consumers are now able to walk into a pharmacy, big box retailer, or favorite e-commerce platform, and access hormonal birth control pills without doctor's appointment or prescription. It is a massive step forward in reducing barriers to accessing healthcare for women.FemTech Focus Podcast bioThe FemTech Focus Podcast is brought to you by FemHealth Insights, the leader in Women's Health market research and consulting. In this show, Dr. Brittany Barreto hosts meaningfully provocative conversations that bring FemTech experts - including doctors, scientists, inventors, and founders - on air to talk about the innovative technology, services, and products (collectively known as FemTech) that are improving women's health and wellness. Though many leaders in FemTech are women, this podcast is not specifically about female founders, nor is it geared toward a specifically female audience. The podcast gives our host, Dr. Brittany Barreto, and guests an engaging, friendly environment to learn about the past, present, and future of women's health and wellness.FemHealth Insights bioLed by a team of analysts and advisors who specialize in female health, FemHealth Insights is a female health-specific market research and analysis firm, offering businesses in diverse industries unparalleled access to the comprehensive data and insights needed to illuminate areas of untapped potential in the nuanced women's health market. Time Stamps[02:10] Flavia and Irene's backgrounds[09:38] Description of Perrigo and explanation of connection to women's health[12:45] What is Opill?[16:02] Other forms of over the counter contraception[20:20] Stats around unintended pregnancy in the US[23:48] Effectiveness of OTC birth control[29:38] The FDA approval process for Opill [32:12] How Perrigo is helping increase access to birth control [35:10] Is Opill right for you?[37:12] Is OTC birth control new to the world? Or just new to the US? [38:50] Looking ahead: aspirations for Opill and Perrigo Episode ContributorsIrene Laurora LinkedIn: @Irene LauroraFlavia MasonLinkedIn: @Flavia Mason OpillWebsite: https://opill.com/ Dr. Brittany BarretoLinkedIn:  @Brittany Barreto, Ph.D.Twitter: @DrBrittBInstagram: @drbrittanybarreto FemTech Focus PodcastWebsite: https://femtechfocus.org/LinkedIn: https://www.linkedin.com/company/femtechfocusTwitter: @FemTech_FocusInstagram: @femtechfocus FemHealth InsightsWebsite: https://www.femhealthinsights.com/LinkedIn: @FemHealth Insights

In this episode, Dr. Shawn Tassone discusses the difference between synthetic and bioidentical hormones. He explains that bioidentical hormones are structurally similar to the body's hormones, while synthetic hormones are structurally different. He also delves into the history of hormone replacement therapy, including the use of pregnant mare's urine and the marketing of Premarin. He dispels myths and misconceptions surrounding bioidentical hormones and emphasizes the importance of understanding the differences between bioidentical and synthetic hormones. Episode Highlights: Bioidentical hormones vs synthetic hormone structure Bioidentical hormones and the FDA The use of the term 'bioidentical' as a descriptive term, not a marketing term Understanding the differences between bioidentical and synthetic hormones Resources Dr. Shawn Tassone's Practice | Tassone Advanced Gynecology Dr. Shawn Tassone's Book | The Hormone Balance Bible Dr. Shawn Tassone's Integrative Hormonal Mapping System | Hormone Archetype Quiz Medical Disclaimer This podcast and website represent the opinions of Dr. Shawn Tassone and his guests. The content here should not be taken as medical advice and is for informational purposes only. Because each person is so unique, please consult your health care professional for any medical questions.

This episode features the amazing Dr. LaKeischa. She is an integrative OB-GYN and hormone specialist. We discuss the complexities of perimenopause and menopause, including how these stages can affect intimate relationships. Dr. LaKeischa opens up about her journey and the transformative power of pain into purpose, while both of us stress the importance of open communication with partners and family to navigate the changes that come with hormonal shifts. The episode also touches on the broader issues within the healthcare system, including mental health access and patient advocacy. Questions This Episode Will Answer: How do perimenopause and menopause impact intimate relationships? What are the broader issues within the healthcare system that affect women's health during hormonal shifts? What advice can help women listen to their bodies and advocate for their health during perimenopause and menopause? Whether you are a woman going through perimenopause or menopause, in a relationship, or want to learn how to better communicate with those in your life, this episode has something for you! Don't worry, you don't have to identify as a woman to get something from this episode. Find Dr. LaKeischa https://instagram.com/drlakeischamd https://facebook.com/drlakeischamd https://linkedin.com/in/drlakeischamd talkhormones.com Resources Get your free Better Mental Health Affirmations: Affirmationbonus.com About Dr. LaKeischa Dr. LaKeischa Webb McMillan was born and raised in Huntsville, Alabama. She earned her undergraduate degree in Biology (cum laude) from Oakwood College, now Oakwood University, and continued her studies at Loma Linda University School of Medicine. In addition to her academic degrees, Dr. LaKeischa is certified in the use of the DiVinci Robotic System for Minimally Invasive Laparoscopic Surgery. Her ability to reach and teach women has expanded through her Best Seller, The Other PMSTM: Your Survival Guide for Perimenopause and Menopause. Her passion for helping women in perimenopause and menopause included her contribution to being on the advisory board of the only FDA Approved physician-designed vaginal lube line, Momentum Intimacy. A gifted speaker, Integrative OB-GYN, hormone specialist, and Amazon Best-Selling Author; Dr. LaKeischa helps women in perimenopause and menopause who are struggling with depleting hormones get their hormones balanced, regain mental sharpness, and have energy to last the entire day. If you want to become a Hormone Hottie follow Dr. LaKeischa on all social media @drlakeischamd.

In today's topic on the Iron Sights podcast we discuss continuous glucose monitors (CGM) and the significance of CGMs as we dissect the recent FDA announcement that has sparked conversation and intrigue.You'll hear why CGMs are garnering attention and what to be aware of in today's health landscape. From understanding the fundamentals to uncovering key considerations, we cover a lot in this episode.Whether you're familiar with CGMs or new to the concept, Cece, Stephen and I will  provide some insights and perspectives to enhance your understanding.25% OFF! Red Dot Fitness Programs: rdfprograms.comTimestamps00:00 Intro02:41 Balancing Intensity And Volume In Your Workout06:51 Constant Glucose Monitor Benefits And Damages10:46 How The Device Works13:46 Why Are Non-Diabetics Using CGM Devices17:36 Using CGM's To Improve Longevity21:38 People's Realization When Using The CGM Devices28:41 Glycemic Index Vs Glycemic Load33:43 What's The Problem With The Information And The Technology42:25 Glucose Monitors Good Or Bad?48:39 Are These Devices Actually Improving Health And Medicine?Red Dot Fitness Training Programs:rdfprograms.comOnline Membership (Full Access To All Programs & Virtual Coaching):https://www.reddotfitness.net/online-membershipVirtual Coaching:https://www.reddotfitness.net/virtual-coachingSelf-Guided Programs:https://www.reddotfitness.net/Self-Guided-Programs1Connect With Us:Website - https://ironsightspodcast.com/Instagram - https://www.instagram.com/ironsightspodcast/Facebook - https://www.facebook.com/

On this episode of the Happy Hour, Michael, Anna and Anthony dive deep into the recent case heard by the Supreme Court revolving around Mifepristone and the FDA's 20-year-old approval of the widely-used abortion drug. Spoiler, the Justices seem likely to uphold the federal approval but it's not without its controversies. The gang also covers the latest goings on in Congress like Mike Gallagher stepping down, bipartisan support for the SNAP program and what to do about the backlog of SIVs (special visas) for out Afghan partners who helped the US Military in our prolonged middle-east wars.

Why is there an outbreak of measles? How do I know if I had the measles vaccine? When will Opill be available? Can you test for colon cancer without colonoscopy? Our guest is AMA's Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH. American Medical Association CXO Todd Unger hosts.

After a roller coaster of feedback (very high highs, lots of questions, some lows) on her bio identical hormone episode, Claire decided to address it head on. In this episode Claire talks about how patients are confused by the very experts they turn to, and offers her thoughts.

Pink Sheet reporters and editors discuss the dismissal of PhRMA's suit challenging the Medicare price negotiation provisions (:30), the US FTC and HHS investigation of drug shortages (12:01), and the potential for FDA-approved marijuana products (23:47). More On These Topics From The Pink Sheet PhRMA's Lawsuit Against Medicare Trips Over ‘Administrative Remedy' Standard; Will Others? https://pink.citeline.com/PS149791/PhRMAs-Lawsuit-Against-Medicare-Trips-Over-Administrative-Remedy-Standard-Will-Others FTC, HHS Probe GPO Contracting Practices As Source Of Generic Drug Shortages: https://pink.citeline.com/PS149790/FTC-HHS-Probe-GPO-Contracting-Practices-As-Source-Of-Generic-Drug-Shortages Prescription Marijuana? FDA Rescheduling Memo Sets Stage To Test Whether There's A Viable Market: https://pink.citeline.com/PS149781/Prescription-Marijuana-FDA-Rescheduling-Memo-Sets-Stage-To-Test-Whether-Theres-A-Viable-Market

Last month the FDA approved a new treatment for sickle cell disease, the first medical therapy to use CRISPR gene editing technology. It works by identifying the gene or genes causing the disorder, modifying those genes and then returning them to the patient's body.There are now two gene therapies offered by pharmaceutical companies for sickle cell disease: Casgevy from Vertex Pharmaceuticals and CRISPR Therapeutics, and Lyfgenia from BlueBird Bio. But prices for these one-time treatments are steep: Casgevy costs $2.2 million per patient and Lyfgenia $3.1 million.Both promise a full cure, which would be life-changing for patients with this debilitating condition. Over 100,000 Americans, mostly of African descent, have sickle cell disease.This milestone raises more questions: What will be the next disease that CRISPR can help cure? And is it possible to reduce the costs of gene therapy treatments?Ira talks with Dr. Fyodor Urnov, professor of molecular and cell biology and scientific director of technology and translation at the Innovative Genomics Institute, based at the University of California, Berkeley, about the future of CRISPR-based cures.Transcripts for this segment will be available the week after the show airs on sciencefriday.com. To stay updated on all things science, sign up for Science Friday's newsletters.

Let's talk AI stories that have been living in my head rent free this week! SHOW NOTES

We invited Dr.  LaKeischa McMillan for this episode to discuss hormone health, perimenopause, menopause, and everything in between!   Research indicates that perimenopause (the pre-menopause stage) is starting earlier for many women, with Black women transitioning even earlier than other races with symptoms starting as soon as the early 30s.  This impacts our mental and physical health, as well as our relationships and work experience. Dr. LaKeischa provides a master class in the episode, breaking down the physiology of what's happening in our bodies, symptoms of perimenopause and menopause, and gives tips on when we may need to reach out for additional medical support when going through this natural transition.   She also provides insights into Black women's particular experience, and shares wisdom on how we can move beyond a deficit-based understanding of menopause and be empowered to thrive in this transition phase of life.     About Dr. LaKeischa Dr. LaKeischa Webb McMillan was born and raised in Huntsville, Alabama. She earned her undergraduate degree in Biology (cum laude) from Oakwood College, now Oakwood University, and continued her studies at Loma Linda University School of Medicine. In addition to her academic degrees, Dr. LaKeischa is certified in the use of the DiVinci Robotic System for Minimally Invasive Laparoscopic Surgery. Her ability to reach and teach women has expanded through her Best Seller, The Other PMS TM : Your Survival Guide for Perimenopause and Menopause. Her passion for helping women in perimenopause and menopause included her contribution to being on the advisory board of the only FDA Approved physician designed vaginal lube line, Momentum Intimacy. A gifted speaker, Integrative OB-GYN, hormone specialist, and Amazon Best-Selling Author; Dr. LaKeischa helps women in perimenopause and menopause who are struggling with depleting hormones get their hormones balanced, regain mental sharpness, and have energy to last the entire day. Connect with Dr. LaKeischa Website: https://www.drlakeischamd.com IG: @drlakeischamd LinkedIn Hormone Quiz: https://www.hormonequiz.co/   Resources: Programs: We are now enrolling for the January 2024 sessions of our Mid-Career and Early Career leadership development programs.  Learn more at https://blackwomanleading.com/programs-overview/ Event: Join us for the Black Woman Leading LIVE! Conference +Retreat, May 13-16, 2024 in Virginia Beach! Learn more at bwlretreat.com   Credits: Learn more about our consulting work with organizations at https://knightsconsultinggroup.com/ Email Laura: laura@knightsconsultinggroup.com Connect with Laura on LinkedIn Follow BWL on LinkedIn Instagram: @blackwomanleading Facebook: @blackwomanleading Podcast Music & Production: Marshall Knights  Graphics: Téa Campbell Listen and follow the podcast on all major platforms: Apple Podcasts Spotify Stitcher iHeartRadio Audible Podbay  

Patrick Bet-David delves deep into the escalating Fentanyl crisis in America, tracing its lethal path from China and Mexico to the heart of American communities. Go to our sponsor https://betterhelp.com/valuetainment for 10% off your first month of therapy with BetterHelp and get matched with a therapist who will listen and help. Connect one-on-one with the right expert to get the answers you need with Minnect! https://bit.ly/47iyBQx Visit Valuetainment University for the best courses online for entrepreneurs: https://bit.ly/47lK559 Get best-in-class business advice with Bet-David Consulting: https://bit.ly/4721sIy Visit VT.com for the latest news and insights from the world of politics, business and entertainment: https://bit.ly/46YLpvd Patrick Bet-David is the founder and CEO of Valuetainment Media. He is the author of the #1 Wall Street Journal Bestseller Your Next Five Moves --- Support this podcast: https://podcasters.spotify.com/pod/show/valuetainment/support

If you struggle with retaining sharp focus or have been diagnosed with ADHD or other conditions that impede your brain from functioning at its optimal level, this is the podcast episode for you. We learn about a (literally) out-of-the-box solution to attention training—video games. Yes, you read that right.Our guest today, Dr. Adam Gazzaley, holds an M.D. and Ph.D. in Neuroscience from Mount Sinai School of Medicine and completed Neurology residency at the University of Pennsylvania, followed by postdoctoral training in cognitive neuroscience at UC Berkeley. He's currently the David Dolby Distinguished Professor at UC San Francisco and the Founder/Executive Director of Neuroscape, a center focusing on technology-driven scientific research. So it's safe to say that Adam is not your prototypical basement gamer.As someone who struggled with focus and attention due to Asperger's syndrome and brain fog due to the effects of toxic mold exposure, figuring out how to retrain my brain to be able to retain more information and focus longer was one of the first areas of biohacking I ever explored. This is why I'm so excited to be talking all about Endeavor Rx today, the world's first FDA-authorized prescription video game treatment for pediatric ADHD—and Endeavor OTC, for adults who struggle with ADHD, focus, attention, and distraction.We explore how we can measure attention and improvement in focus, the biological systems that control what we focus on consciously and subconsciously, the role of nutrition in our ability to focus, the underlying technology of Endeavor, measuring its effectiveness, and Adam's vision for how we can use biosensing technology—now and in the future—to optimize awareness, focus, mood, and more. (03:07) Addressing Modern Attention Challenges• Defining our attention systems and how to measure them• How I learned how to pay attention, even with ADHD• Read: The Distracted Mind by Adam Gazzaley and Larry D. Rosen• Tools we have for addressing attention challenges• What I use now for brain function and focus• The role nutrition plays in being able to focus• What typical of video games can aid in training attention • The potential negative effects of shooter games (20:37) Understanding Endeavor: How to Train Attention Using a Video Game• Top down vs. bottom up thinking• Endeavor: the video game that trains your attention• The journey of getting Endeavor approved by the FDA• The effectiveness of Endeavor for adults• What to expect from playing Endeavor• How you can utilize multimodal biosensing for quantifying physiology• Hugs from Dr. Love with Paul Zak – #334• Exploring what technology is used in a sensory immersion lab, including AI(49:21) Exploring Potential Costs & Opportunities of Biosensing Technology• Understanding the potential adverse effects or downsides of this technology• Join the Live Audience: ourupgradecollective.com• The exhaustion factor in playing Endeavor• What video games would be likely to reduce cognitive function• Using Lion's Mane for increasing brain function• What this system could look like in 10 years ResourcesDave Asprey's NEW Book ‘Smarter Not Harder' is out now: https://daveasprey.com/books Endeavor OTC: https://www.endeavorotc.com/Instagram: https://www.instagram.com/endeavorotc/Website: https://gazzaley.com/Instagram: https://www.instagram.com/adamgazz/The Human Upgrade is produced by Crate Media.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Rod and Karen discuss Fyre Festival II, man crashes hot air balloon while on coke, people are losing more money to scammers than ever, Arby's buys Subway, iPhone will have to pay people for slowing down their phones, one quarter to adult children are estranged from a parent, AK school fighting over AP African American studies, new FDA-Approved preeclampsia blood test could lower maternal death rate for Black people, woman robs man after faking being his Uber driver, cop throws McDonald's burger at wife, Burger King employee didn't take a sick day in 20 years and sword ratchetness. Twitter: @rodimusprime @SayDatAgain @TBGWT Instagram: @TheBlackGuyWhoTips Email: theblackguywhotips@gmail.com Blog: www.theblackguywhotips.com Teepublic Store Amazon Wishlist Crowdcast Voice Mail: 704-557-0186 Live Show Tickets Sponsor: Joy Stick Angels Kickstarter

The death rate for young adult Americans, the people who are supposed to be in peak physical health, has surged abruptly over the past few years. In fact, the surge matches almost exactly with the rollout of Covid vaccines — and vaccine mandates — in early 2021. So when will public officials finally allow people to ask whether the obvious cause is the actual one? Charlie speaks to Dr. Pierre Kory about his op-ed on this surge in deaths, as well as a recent FDA admission that doctors are free to prescribe Ivermectin. Plus, Alan Dershowitz responds to the imminent fourth indictment of Donald Trump, which may be the most outlandish one yet.Support the show: http://www.charliekirk.com/supportSee omnystudio.com/listener for privacy information.